Page last updated: 2024-10-24

peptidase complex

Definition

Target type: cellularcomponent

A protein complex which is capable of peptidase activity. [GO_REF:0000088, GOC:bhm, GOC:TermGenie, PMID:1689240]

Peptidase complexes are multi-protein assemblies that play crucial roles in a wide range of cellular processes, including protein degradation, signal transduction, and regulation of gene expression. These complexes are characterized by their ability to cleave peptide bonds within proteins, a process known as proteolysis. The composition and organization of peptidase complexes vary greatly, depending on the specific function and cellular context. However, they often share common features, such as the presence of catalytic subunits responsible for proteolytic activity and regulatory subunits that control complex assembly, substrate specificity, and activity. The cellular component of a peptidase complex can be described as a dynamic and intricate network of proteins, often localized to specific cellular compartments, where they interact and cooperate to achieve their biological functions. These complexes are essential for maintaining cellular homeostasis and respond to various stimuli, enabling cells to adapt to changing conditions. Specific examples of peptidase complexes include the proteasome, a large multi-subunit complex involved in protein degradation, and the signal peptidase complex, which cleaves signal peptides from newly synthesized proteins.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Prolyl endopeptidase FAPA prolyl endopeptidase FAP that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q12884]Homo sapiens (human)

Compounds (11)

CompoundDefinitionClassesRoles
n-carbobenzoxyglycyl-prolyl-4-methylcoumarinyl amideN-carbobenzoxyglycyl-prolyl-4-methylcoumarinyl amide: fluorogenic substrate for post-proline cleaving enzyme
sitagliptinsitagliptin : A triazolopyrazine that exhibits hypoglycemic activity.triazolopyrazine;
trifluorobenzene
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
environmental contaminant;
hypoglycemic agent;
serine proteinase inhibitor;
xenobiotic
vildagliptinamino acid amide
talabostattalabostat: an antineoplastic agent; structure in first source
linagliptinlinagliptin : A xanthine that is 7H-xanthine bearing (4-methylquinazolin-2-yl)methyl, methyl, but-2-yn-1-yl and 3-aminopiperidin-1-yl substituents at positions 1, 3, 7 and 8 respectively (the R-enantiomer). Used for treatment of type II diabetes.

Linagliptin: A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS.
aminopiperidine;
quinazolines
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
hypoglycemic agent
kyp 2047
bms 477118adamantanes;
azabicycloalkane;
monocarboxylic acid amide;
nitrile;
tertiary alcohol
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
hypoglycemic agent
alogliptinalogliptin : A piperidine that is 3-methyl-2,4-dioxo-3,4-dihydropyrimidine carrying additional 2-cyanobenzyl and 3-aminopiperidin-1-yl groups at positions 1 and 2 respectively (the R-enantiomer). Used in the form of its benzoate salt for treatment of type 2 diabetes.

alogliptin: structure in first source
nitrile;
piperidines;
primary amino compound;
pyrimidines
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
hypoglycemic agent
gosogliptinamino acid amide
anagliptinanagliptin: anagliptin hydrochloride salt is the active compoundamino acid amide
mk-3102pyrrolopyrazole